✦ LIBER ✦

Clinical recognition and management of depression in node negative breast cancer patients treated with tamoxifen

✍ Scribed by Cynthia K. Cathcart; Stephen E. Jones; C. Sue Pumroy; George N. Peters; Sally M. Knox; J. Harold Cheek

Publisher: Springer US
Year: 1993
Tongue: English
Weight: 387 KB
Volume: 27
Category: Article
ISSN: 0167-6806
DOI: 10.1007/bf00665698

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical pharmacology of tamoxifen in pa

Clinical pharmacology of tamoxifen in patients with breast cancer: Correlation with clinical data

✍ Carol Fabian; Larry Sternson; Moustafa El-serafi; Lyn Cain; Erwin Hearne 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 643 KB

Detection of micrometastases in axillary

Detection of micrometastases in axillary lymph nodes of node-negative breast cancer patients and its clinical significance

✍ Jindong Wu; Zihao Yu; Guomin Li; Hongtu Zhang 📂 Article 📅 1997 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 242 KB

TSC22D1 and PSAP predict clinical outcom

TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer

✍ Danielle Meijer; Maurice P. H. M. Jansen; Maxime P. Look; Kirsten Ruigrok-Ritsti 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 330 KB

A 10-year follow-up of treatment outcome

A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance

✍ A. Gabriella Wernicke; Robert L. Goodman; Bruce C. Turner; Lydia T. Komarnicky; 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 336 KB

Overexpression of Id-1 is associated wit

Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer

✍ Sebastian F. Schoppmann; Monika Schindl; Guenther Bayer; Klaus Aumayr; Julia Die 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 427 KB 👁 1 views

## Abstract Id‐1 is an important regulator of cellular growth and differentiation and controls malignant progression of breast cancer cells. The aim of our study was to assess the clinical impact of Id‐1 expression in breast cancer, __i.e.__, its potential impact on prognosis and prediction of trea

Impact of axillary lymph node dissection

Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients : A Systematic Review and Meta-Analysis

✍ Mona Sanghani; Ethan M. Balk; Blake Cady 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB 👁 2 views

## Abstract ## BACKGROUND: The regional lymph node control and survival impact of axillary dissection in breast cancer has been the subject of multiple randomized trials, with various results. This study reviews and conducts a meta‐analysis of contemporary trials of axillary dissection in patients